reports
- ABGSC Financials Research
- Jan Erik Gjerland
- Magnus Andersson
- Patrik Brattelius
- ABGSC IT Research
- Oscar Rönnkvist
- Simon Jönsson
Marathon Digital Holdings Schedules Conference Call for First Quarter ...
Marathon Digital Holdings Schedules Conference Call for First Quarter 2024 Financial Results Earnings Webcast and Conference Call Set for Thursday, May 9, 2024 at 5:00 p.m. ET Fort Lauderdale, FL, April 24, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:) ("Marathon" or "Company"), one of the world’s largest publicly traded Bitcoin miners and a leader in supporting and securing the Bitcoin ecosystem, will hold a webcast and conference call on Thursday, May 9, 2024 at 5:00 p.m. Eastern time to discuss its financial results for the first quarter ended March 31, 2024. Financial results will be published...
Toll Brothers Announces Clubhouse Grand Opening Event on May 4 at Rege...
Toll Brothers Announces Clubhouse Grand Opening Event on May 4 at Regency at Santa Rita Ranch 55+ Community in Liberty Hill, Texas Luxury active-adult community features three collections of single-family homes and resort-style amenities LIBERTY HILL, Texas, April 24, 2024 (GLOBE NEWSWIRE) -- (NYSE:TOL), the nation’s leading builder of luxury homes, is hosting a clubhouse grand opening celebration at its community of luxury homes for 55+ active adults located in vibrant Liberty Hill, Texas. The event will be held on Saturday, May 4 from 10 a.m. to 2 p.m. at 220 Flower Valley Parkwa...
Blue Line Protection Group Provides Financial Review
Blue Line Protection Group Provides Financial Review Denver, CO, April 24, 2024 (GLOBE NEWSWIRE) -- Blue Line Protection Group Inc. (OTCQB: BLPG) is pleased to summarize the 2023 financial results. 2023 was a profitable year for the Company, as shown in our 10K filing. Revenue grew by 13% respectively, and operating income rose to an impressive $762,713. Total assets grew by $478,493 and shareholders deficit was reduced by $518,470. Additionally, the Company processed over $1,400,000,000 in cash pickups throughout 2023, with that number anticipated to increase in 2024. As our presence an...
ADT Names Jeff Likosar as Chief Financial Officer
ADT Names Jeff Likosar as Chief Financial Officer BOCA RATON, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- (NYSE: ADT), the most trusted brand in smart home and small business security, announced today that Jeff Likosar has been named Chief Financial Officer. In addition to his duties as President, Corporate Development and Chief Transformation Officer, which he will retain, Likosar had been serving as interim CFO since December 2023. He previously served as the company’s CFO from 2017 to 2022. Along with customary CFO responsibilities, Likosar will remain responsible for corporate develo...
INNOVATE Corp. Announces Closing of Rights Offering
INNOVATE Corp. Announces Closing of Rights Offering NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today the closing of its successful rights offering, which expired at 5:00 p.m., New York City time, on April 19, 2024. Pursuant to the terms of the rights offering, 5.2 million shares of common stock are being purchased pursuant to the exercise of basic subscription rights and 0.1 million additional shares of common stock are being purchased under the over-subscription privilege. In accordance...
Mueller Water Products Announces Dates for Second Quarter 2024 Earning...
Mueller Water Products Announces Dates for Second Quarter 2024 Earnings Release and Conference Call ATLANTA, April 24, 2024 (GLOBE NEWSWIRE) -- Mueller Water Products, Inc. (NYSE: MWA) plans to release financial results for its second quarter ended March 31, 2024, after U.S. markets close on Monday, May 6, 2024. On Tuesday, May 7, 2024, at 10:00 a.m. ET, the Company will hold a conference call to discuss earnings and business results. Interested parties are invited to listen via webcast available on the Investor Relations section of the Company’s website . An archive of the webcast will b...
Amedisys Reports First Quarter 2024 Financial Results
Amedisys Reports First Quarter 2024 Financial Results BATON ROUGE, La., April 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2024. Three-Month Periods Ended March 31, 2024 and 2023 Net service revenue increased $15.0 million to $571.4 million compared to $556.4 million in 2023. Prior year included $15.0 million of net service revenue from our personal care business which was divested on March 31, 2023.Net income attributable to Amedisys, Inc. of $14.4 million, which is inclusive of merger-relat...
CVB Financial Corp. Reports Earnings for the First Quarter 2024
CVB Financial Corp. Reports Earnings for the First Quarter 2024 First Quarter 2024 Net Earnings of $48.6 million, or $0.35 per share Return on Average Assets of 1.21%Return on Average Tangible Common Equity of 15.13% Net Interest Margin of 3.10% ONTARIO, CA, April 24, 2024 (GLOBE NEWSWIRE) -- CVB Financial Corp. (NASDAQ:CVBF) and its subsidiary, Citizens Business Bank (the “Company”), announced earnings for the quarter ended March 31, 2024. CVB Financial Corp. reported net income of $48.6 million for the quarter ended March 31, 2024, compared with $48.5 million ...
Riot Announces First Quarter 2024 Earnings Conference Call
Riot Announces First Quarter 2024 Earnings Conference Call Castle Rock, CO, April 24, 2024 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ: RIOT) (“Riot” or “the Company”), an industry leader in vertically integrated Bitcoin (“BTC”) mining, announced today that it has scheduled its first quarter 2024 earnings conference call for Wednesday, May 1, 2024, at 8:30 A.M. EST. During the call, Riot will discuss the results for the quarter ended March 31, 2024. This conference call will be available through the audio webcast, please use this link . Additionally, participants can join the con...
NKGen Biotech Announces Upcoming Publication at the 2024 American Soci...
NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting SANTA ANA, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer (“NK”) cell therapeutics, today announced an online publication at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting to be held virtually and at the McCormick Place Convention Center...
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Nouryon Holding B.V. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 23 April 2024 in which Moody's reassessed the appropriateness of the ratings in the co...
- Benjamin Schroeder
- Michiel Tukker
- Padhraic Garvey
- CFA
Rates Spark: Upbeat sentiment helps yields higher
Positive risk sentiment is helping yields up and was reflected in solid demand for Greece's 30y bond sale. Euro rates will now focus on this week's US PCE reading as the impact is likely to spill over into the market pricing for 2024 European Central Bank cuts
Moody's Ratings assigns provisional ratings to six CMBS classes of MED...
Moody's Ratings (Moody's) has assigned provisional ratings to six classes of CMBS securities, to be issued by MED Commercial Mortgage Trust 2024-MOB, Commercial Mortgage Pass-Through Certificates, Series 2024-MOB: Cl. A, Assigned (P)Aaa (sf) Cl. B, Assigned (P)Aa1 (sf) Cl. C, Assigned (P)A2 (sf)...
Kroger Co: 4 directors
Four Directors at Kroger Co sold after exercising options/sold 131,705 shares at between 55.520USD and 57.180USD. The significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the com...
- ABGSC IT Research
- Øystein Elton Lodgaard
- ABGSC Online Gaming Research
- Oscar Rönnkvist
- Simon Jönsson
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financi...
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel radioenhancer NBTXR3Prolonged survival in Study 102 reinforces pivotal NANORAY-312 trial design in head and neck cancer; initial efficacy and favorable safety profile supports potential of NBTXR3 in pancreatic cancer; determined RP2D for MD Anderson lung studyMultiple clinical readouts expected in 2024 including immunotherapy combination data from Study 1100, and data ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.